Impact Factor
3.63
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.08
593 total citations
h5-index
35
h5 depth signal
Cited share
73.8%
121 of 164
Total citations
593
Citation footprint
Metric signal
3.57
External metric anchor
Self-citation
1.3%
8 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
473
China
114
Japan
67
Canada
51
United Kingdom
47
Citing Fields of Research
Kidney Diseases
966
Urology
373
Cardiology
118
Transplantation
112
Diabetes
88
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,172
Articles tracked across the journal lifetime
Indexed publication set
164
121 cited publications
Last 12 months
87
7.3 publications/month
Open access share
35.6%
31 OA publications in the last year
Leading citing country
United States
473 citing publications
Leading citing field
Kidney Diseases
966 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1981-
v1n1, 1981-
Active Coverage
Research Focus & Classification
Indexed Subjects
Kidney Diseases
Broad Categories
Nephrology
Urology
MeSH Descriptors
Nephrology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1159/ajn/ablag025
Open DOI
Daily Caloric Restriction in Overweight and Obese Adults with ADPKD: Rationale and Protocol of a Randomized Controlled Trial
Introduction: Mounting evidence suggests dysregulated metabolism as a feature of autosomal dominant polycystic kidney disease (ADPKD) and that mild-to-moderate food restriction significantly slows cyst growth in murine models. Epidemiolo...
02
DOI 10.1159/ajn/ablag027
Open DOI
Fluid Intake and Kidney Function: A Systematic Review and Dose–Response Meta-analysis
Introduction: Fluid intake is widely recommended in clinical practice, yet evidence linking habitual fluid intake to kidney outcomes remains inconsistent. We evaluated dose–response associations between fluid intake volume and kidney fun...
03
DOI 10.1159/ajn/ablag026
Open DOI
Urinary biomarkers at hospital admission and community-acquired acute kidney injury: A prospective cohort
Background: We aimed to determine the sensitivity and specificity of a 13-urinary biomarker (uBM) panel for identifying community-acquired acute kidney injury (CA-AKI) and to assess whether these biomarkers were independently associated ...
04
DOI 10.1159/ajn/ablag024
Open DOI
Deciphering the Molecular and Cellular Landscape of Early Diabetic Nephropathy through Single-Cell RNA Sequencing and Protein-Protein Interaction Networks
Diabetic nephropathy (DN) arises through complex pathological mechanisms that remain incompletely understood. This study employs transcriptomic and single-cell RNA sequencing (scRNA-seq) approaches to systematically characterize gene exp...
05
DOI 10.1159/ajn/ablag021
Open DOI
Tubuloreticular Inclusions in Kidney Tissues of Patients with Lupus Nephritis: An Ultrastructural Biomarker of Type I Interferon-Driven Disease Activity
Background. Tubuloreticular inclusions (TRIs) in kidney tissues associate with type I interferon (IFN-I) pathway activation, but their clinical and pathological significance in lupus nephritis (LN) remains incompletely defined. Methods. ...
06
DOI 10.1159/ajn/ablag016
Open DOI
Risk of kidney failure in biopsy-verified kidney disease type in type 2 diabetes: A registry-based longitudinal cohort study
Introduction. The risk of kidney failure (KF) varies among people with diabetes and chronic kidney disease. We aimed to investigate whether the risk of progression to KF differs by biopsy-proven type of kidney disease in type 2 diabetes ...
07
DOI 10.1159/ajn/ablag015
Open DOI
RealxWorld Effectiveness of Targeted-Release Budesonide in IgA Nephropathy with Near-Universal SGLT2 Inhibitor Use
Background: IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide and a leading cause of end-stage kidney disease. Targeted-release formulation (TRF) budesonide demonstrated significant reductions in proteinuria ...
08
DOI 10.1159/ajn/ablag018
Open DOI
Integrated Analysis of the aKlotho–FGF23–FGFR Genetic Axis Reveals Determinants of Cardiovascular Risk in Chronic Kidney Disease
Introduction: Chronic kidney disease (CKD) is associated with a markedly increased cardiovascular (CV) risk. The disruption of the αKlotho–Fibroblast Growth Factor 23 (FGF23)–FGF receptors (FGFR) axis has been implicated in chronic disea...
09
10
DOI 10.1159/ajn/ablag029
Open DOI
The Solitary Functioning Kidney: From Pathophysiology to Long-Term Management
Solitary functioning kidney (SFK) is a clinical condition characterized by the presence of a single functioning kidney, arising from either congenital anomalies or acquired causes. It is recognized as an important risk factor for chronic...
Bibliographical & Catalog Notes
Title from cover.
Also available online.
Vol. 12, no. 1 (1992)19921001 Notice published Printed on acid-free paper